Regulation of tissue repair pathways

"Regulation of tissue repair pathways" refers not to a single molecule or receptor, but to a complex, coordinated network of cellular and molecular processes that restore tissue integrity after injury. These pathways are driven by the dynamic interplay of growth factors (e.g., TGF-β, PDGF, EGF, VEGF, FGF), cytokines, integrins, and extracellular matrix (ECM) components, which collectively mediate hemostasis, inflammation, cell proliferation, migration, angiogenesis, and matrix remodeling[1][2][3]. Key molecular players include integrins (mediating cell-ECM communication and activating intracellular signaling cascades such as FAK/ERK and PI3K/Akt), matrix metalloproteinases (MMPs) for ECM turnover, and a variety of cell types (keratinocytes, fibroblasts, macrophages, endothelial cells) that respond to local signals to rebuild tissue[1][3]. Dysregulation of these pathways can lead to pathological outcomes such as chronic wounds, excessive scarring, or fibrosis[1][2]. While individual components (e.g., TGF-β receptor, integrins, MMPs) are recognized therapeutic targets, the overall "regulation of tissue repair pathways" is a biological process, not a single druggable target. Thus, this entry does not represent a molecule or receptor, but rather a collection of pathways and mechanisms involved in tissue repair and regeneration.

Other names

Tissue repair signalingWound repair pathwayWound healing pathwayCellular repair pathwayInjury response pathway